Oppenheimer & Co. Inc. Acquires 20,740 Shares of Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer & Co. Inc. grew its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 139.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,635 shares of the company's stock after purchasing an additional 20,740 shares during the quarter. Oppenheimer & Co. Inc.'s holdings in Doximity were worth $1,553,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. LRI Investments LLC purchased a new position in Doximity during the first quarter worth about $27,000. Farther Finance Advisors LLC lifted its holdings in shares of Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Blue Trust Inc. raised its position in Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock valued at $37,000 after buying an additional 1,193 shares during the period. Quarry LP increased its position in Doximity by 101.2% in the 2nd quarter. Quarry LP now owns 1,616 shares of the company's stock worth $45,000 after purchasing an additional 131,253 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in shares of Doximity during the 1st quarter worth about $46,000. Hedge funds and other institutional investors own 87.19% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Needham & Company LLC raised Doximity from a "hold" rating to a "buy" rating and set a $38.00 target price for the company in a research note on Friday, August 9th. The Goldman Sachs Group initiated coverage on shares of Doximity in a report on Friday. They set a "neutral" rating and a $58.00 price target for the company. Evercore ISI increased their price objective on shares of Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Baird R W upgraded shares of Doximity to a "strong-buy" rating in a research note on Tuesday, September 17th. Finally, KeyCorp upgraded shares of Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 price objective on the stock in a research report on Friday, November 8th. Eleven research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Doximity has a consensus rating of "Hold" and a consensus price target of $51.07.

Doximity Stock Up 4.7 %

Shares of NASDAQ:DOCS traded up $2.31 during midday trading on Monday, hitting $51.71. The stock had a trading volume of 935,720 shares, compared to its average volume of 1,736,756. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75. The company has a market capitalization of $9.65 billion, a P/E ratio of 58.76, a price-to-earnings-growth ratio of 4.09 and a beta of 1.30. The company's 50-day moving average price is $43.40 and its 200-day moving average price is $34.25.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.